Whole Network Gene Therapy Microbiology Nanomedicine Stem Cells

 

Amgen's Denosumab Increases Bone Mineral Density in Phase 2 Clinical Trials

Filed in archive Drugs, Vaccines and Therapeutics by ruth on February 27, 2006

Drug Therapy for Osteoporosis

Amgen released the results of Phase 2 clinical trials for Denosumab (previously referred to as AMG 162), showing that the RANK Ligand inhibitor significantly increased bone mineral density (BMD) in the total hip, lumbarlinks spine, distal 1/3 radius and total body. Results are published in the recent issue of the New England Journal of Medicine.

"These exciting data suggest that denosumab, when administered in twice-yearly injections, may show promise in the treatment of osteoporosis," said Michael McClung, MD, FACP, principal investigator of the denosumab study, Providence Portland Medical Center, and director of the Oregon Osteoporosis Center, Portland, Ore. "Continued research will further our understanding of the potential of denosumab in bone loss management."


Read more about Denosumab, the study design and osteoporosis from Amgen's press release.






Permalink: Amgen's Denosumab Increases Bone Mineral Density in Phase 2 Clinical Trials
Tags: osteoporosis  amgen  biotech  clinical  denosumab  phase+clinical  clinical+trials  mineral+density 

Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/16404





RSSrss   | See all blog subscribe options
Google google   |   What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter
Grouptivity

Use the search to look for other interesting posts



 
  • Advertise with us

  • Learn more about our advertising options or email advertising - at - creative-weblogging.com or give us a call at +1 (650) 331 4900.


  • Testimonials

  • 'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

    'I subscribe to your blog and have been enjoying your posts and perspective.'


  • Other blogs in the same channel in the Creative Weblogging Network







 

Tagcloud: Biotech Hubs and Facilities Biotech/Science Blogs Corporate and Industrial News Diagnostics, Methodologies and Instrumentation Drugs, Vaccines and Therapeutics Energy, Environment and Ecology Food and Agriculture Gene Therapy Genomics, Proteomics and Bioinformatics Meetings and Other Events Microbiology Nanomedicine Other Biotechnology News Patents and Intellectual Property Rights Sponsored Post Stem Cells